Leyton J - Search Results

1

Enhanced in vivo platelet "release reaction" in old healthy individuals.

Zahavi J, Jones NA, Leyton J, Dubiel M, Kakkar VV. Zahavi J, et al. Among authors: leyton j. Thromb Res. 1980 Feb 1-15;17(3-4):329-36. doi: 10.1016/0049-3848(80)90067-5. Thromb Res. 1980. PMID: 6445093 No abstract available.

2

Plasma exchange and platelet function in Raynaud's phenomenon.

Zahavi J, Hamilton WA, O'Reilly MJ, Leyton J, Cotton LT, Kakkar VV. Zahavi J, et al. Among authors: leyton j. Thromb Res. 1980 Jul 1-15;19(1-2):85-93. doi: 10.1016/0049-3848(80)90406-5. Thromb Res. 1980. PMID: 6449756 No abstract available.

3

A Novel Proteomic Method Reveals NLS Tagging of T-DM1 Contravenes Classical Nuclear Transport in a Model of HER2-Positive Breast Cancer.

Lacasse V, Beaudoin S, Jean S, Leyton JV. Lacasse V, et al. Among authors: leyton jv. Mol Ther Methods Clin Dev. 2020 Sep 1;19:99-119. doi: 10.1016/j.omtm.2020.08.016. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33024794 Free PMC article.

4

Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?

Bednova O, Leyton JV. Bednova O, et al. Among authors: leyton jv. Int J Mol Sci. 2020 Oct 1;21(19):7268. doi: 10.3390/ijms21197268. Int J Mol Sci. 2020. PMID: 33019653 Free PMC article. Review.

5

Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics-The Tale of HER2.

Leyton JV. Leyton JV. Antibodies (Basel). 2020 Jul 13;9(3):32. doi: 10.3390/antib9030032. Antibodies (Basel). 2020. PMID: 32668710 Free PMC article. Review.

6

A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts.

Paquette M, Phoenix S, Lawson C, Guérin B, Lecomte R, Tai LH, Turcotte ÉE, Leyton JV. Paquette M, et al. Among authors: leyton jv. EJNMMI Res. 2020 Jun 26;10(1):69. doi: 10.1186/s13550-020-00656-8. EJNMMI Res. 2020. PMID: 32592121 Free PMC article.

7

Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.

Williams BA, Law A, Hunyadkurti J, Desilets S, Leyton JV, Keating A. Williams BA, et al. Among authors: leyton jv. J Clin Med. 2019 Aug 20;8(8):1261. doi: 10.3390/jcm8081261. J Clin Med. 2019. PMID: 31434267 Free PMC article. Review.

8

CD16⁺NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice.

Williams BA, Wang XH, Leyton JV, Maghera S, Deif B, Reilly RM, Minden MD, Keating A. Williams BA, et al. Among authors: leyton jv. Haematologica. 2018 Oct;103(10):1720-1729. doi: 10.3324/haematol.2017.187385. Epub 2018 Jul 5. Haematologica. 2018. PMID: 29976748 Free PMC article.

9

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting.

Beaudoin S, Paquette M, Fafard-Couture L, Tremblay MA, Lecomte R, Guérin B, Leyton JV. Beaudoin S, et al. Among authors: leyton jv. J Vis Exp. 2018 Mar 8;(133):55440. doi: 10.3791/55440. J Vis Exp. 2018. PMID: 29578523 Free PMC article.

10

NLS-Cholic Acid Conjugation to IL-5Rα-Specific Antibody Improves Cellular Accumulation and In Vivo Tumor-Targeting Properties in a Bladder Cancer Model.

Paquette M, Beaudoin S, Tremblay MA, Jean S, Lopez AF, Lecomte R, Guérin B, Bentourkia M, Sabbagh R, Leyton JV. Paquette M, et al. Among authors: leyton jv. Bioconjug Chem. 2018 Apr 18;29(4):1352-1363. doi: 10.1021/acs.bioconjchem.8b00077. Epub 2018 Mar 1. Bioconjug Chem. 2018. PMID: 29433309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results